We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 23 NOVEMBER 2006
Canada Amends Regulations Governing Generic Drug Approval Process

Blake, Cassels & Graydon LLP
Contributor

Blake, Cassels & Graydon LLP
As one of Canada’s top business law firms, Blake, Cassels & Graydon LLP (Blakes) provides...
View firm profileThe Canadian government has announced substantial amendments to the Patented Medicines (Notice of Compliance) Regulations (the NOC Regulations) and the Food and Drug Regulations (the FD Regulations) that will significantly alter the nature of litigation between innovator and generic drug companies.
CanadaIntellectual Property



